Genes required for the fitness of Salmonella enterica serovar Typhimurium during infection of immunodeficient gp91-/- phox mice

Infection and Immunity

Volumn 84, Issue 4, 2016, Pages 989-997

  Grant, Andrew J ^a   Oshota, Olusegun ^a   Chaudhuri, Roy R ^a,c   Mayho, Matthew ^b   Peters, Sarah E ^a   Clare, Simon ^b   Maskell, Duncan J ^a   Mastroeni, Pietro ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 91; LIVE VACCINE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SALMONELLOSIS VACCINE; BACTERIAL PROTEIN; BACTERIAL VACCINE; CYBB PROTEIN, MOUSE; MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CONTROLLED STUDY; GENE MUTATION; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLOSIS; TRANSPOSON; WILD TYPE; ALLELE; ANIMAL; C57BL MOUSE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; MUTATION; PATHOGENICITY; PHYSIOLOGY; SALMONELLA INFECTIONS, ANIMAL; VIRULENCE;

ALLELES; ANIMALS; BACTERIAL PROTEINS; BACTERIAL VACCINES; GENE EXPRESSION REGULATION, BACTERIAL; IMMUNOCOMPROMISED HOST; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; NADPH OXIDASE; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; VIRULENCE;

EID: 84962811927     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01423-15     Document Type: Article

References (36)

1. Crump JA, Mintz ED. 2010. Global trends in typhoid and paratyphoid Fever. Clin Infect Dis 50:241-246. http://dx.doi.org/10.1086/649541.
2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabriel SE, et al. 2012. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095-2128. http://dx.doi.org/10.1016/S0140-6736(12)61728-0.
3. Ao TT, Feasey NA, Gordon MA, Keddy KH, Angulo FJ, Crump JA. 2015. Global burden of invasive nontyphoidal Salmonella disease 2010. Emerg Infect Dis 21:6.
4. Gordon MA, Banda HT, Gondwe M, Gordon SB, Boeree MJ, Walsh AL, Corkill JE, Hart CA, Gilks CF, Molneux ME. 2002. Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS 16:1633-1641. http://dx.doi.org/10.1097/00002030-200208160-00009.
5. Gordon MA. 2008. Salmonella infections in immunocompromised adults. J Infect 56:413-422. http://dx.doi.org/10.1016/j.jinf.2008.03.012.
6. Gordon MA, Graham SM, Walsh AL, Wilson L, Phiri A, Molyneux E, Zijlstra EE, Heyderman RS, Hart CA, Molyneux ME. 2008. Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica Serovar typhimurium infection associated with multidrug resistance among adults and children in Malawi. Clin Infect Dis 46:963-969. http://dx.doi.org/10.1086/529146.
7. Harrison JA, Villarreal-Ramos B, Mastroeni P, Demarco de Hormaeche R, Hormaeche CE. 1997. Correlates of protection induced by live Aro-Salmonella typhimurium vaccines in the murine typhoid model. Immunology 90:618-625. http://dx.doi.org/10.1046/j.1365-2567.1997.00158.x.
8. MacLennan CA, Martin LB, Micoli F. 2014. Vaccines against invasive Salmonella disease: current status and future directions. Hum Vaccin Immunother 10:1478-1493. http://dx.doi.org/10.4161/hv.29054.
9. Mastroeni P, Harrison JA, Robinson JH, Clare S, Khan S, Maskell DJ, Dougan G, Hormaeche CE. 1998. Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in BALB/c mice: role of gamma interferon and macrophage activation. Infect Immun 66:4767-4776.
10. Sinha K, Mastroeniv P, Harrison J, de Hormaeche RD, Hormaeche CE. 1997. Salmonella typhimurium aroA, htrA, and aroD htrA mutants cause progressive infections in athymic (nu/nu) BALB/c mice. Infect Immun 65:1566-1569.
11. Vazquez-Torres A, Xu Y, Jones-Carson J, Holden DW, Lucia SM, Dinauer MC, Mastroeni P, Fang FC. 2000. Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science 287:1655-1658. http://dx.doi.org/10.1126/science.287.5458.1655.
12. Gilchrist JJ, MacLennan CA, Hill AV. 2015. Genetic susceptibility to invasive Salmonella disease. Nat Rev Immunol 15:452-463. http://dx.doi.org/10.1038/nri3858.
13. Mastroeni P, Ugrinovic S, Chandra A, MacLennan C, Doffinger R, Kumararatne D. 2003. Resistance and susceptibility to Salmonella infections: lessons from mice and patients with immunodeficiencies. Rev Med Microbiol 14:53-62. http://dx.doi.org/10.1097/00013542-200304000-00002.
14. Khan SA, Stratford R, Wu T, Mckelvie N, Bellaby T, Hindle Z, Sinha KA, Eltze S, Mastroeni P, Pickard D, Dougan G, Chatfield SN, Brennan FR. 2003. Salmonella typhi and S. typhimurium derivatives harbouring deletions in aromatic biosynthesis and Salmonella pathogenicity island-2 (SPI-2) genes as vaccines and vectors. Vaccine 21:538-548. http://dx.doi.org/10.1016/S0264-410X(02)00410-3.
15. Langridge GC, Phan MD, Turner DJ, Perkins TT, Parts L, Haase J, Charles I, Maskell DJ, Peters SE, Dougan G, Wain J, Parkhill J, Turner AK. 2009. Simultaneous assay of every Salmonella Typhi gene using one million transposon mutants. Genome Res 19:2308-2316. http://dx.doi.org/10.1101/gr.097097.109.
16. Hoiseth SK, Stocker BA. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 21:238-239.
17. Chaudhuri RR, Peters SE, Pleasance SJ, Northern H, Willers C, Paterson GK, Cone DB, Allen AG, Owen PJ, Shalom G, Stekel DJ, Charles IG, Maskell DJ. 2009. Comprehensive identification of Salmonella enterica serovar typhimurium genes required for infection of BALB/c mice. PLoS Pathog 5(7):e1000529. http://dx.doi.org/10.1371/journal.ppat.1000529.
18. Chang CY, Cohen SN. 1978. Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J Bacteriol 134:1141-1156.
19. Bolivar F, Rodriguez RL, Greene PJ, Betlach MC, Heyneker HL, Boyer HW. 1977. Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene 2:95-113.
20. Mo E, Peters SE, Willers C, Maskell DJ, Charles IG. 2006. Single, double and triple mutants of Salmonella enterica serovar Typhimurium degP (htrA), degQ (hhoA), and degS (hhoB) have diverse phenotypes on exposure to elevated temperature and their growth in vivo is attenuated to different extents. Microb Pathog 41:174-182. http://dx.doi.org/10.1016/j.micpath.2006.07.004.
21. Dower WJ, Miller JF, Ragsdale CW. 1988. High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res 16:6127-6145. http://dx.doi.org/10.1093/nar/16.13.6127.
22. Sambrook J, Russell D. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
23. Muyrers JPP, Zhang Y, Testa G, Stewart AF. 1999. Rapid modification of bacterial artificial chromosomes by ET-recombination. Nucleic Acids Res 27:1555-1557. http://dx.doi.org/10.1093/nar/27.6.1555.
24. Yu D, Ellis HM, Lee EC, Jenkins NA, Copeland NG, Court DL. 2000. An efficient recombination system for chromosome engineering in Escherichia coli. Proc Natl Acad Sci U S A 97:5978-5983. http://dx.doi.org/10.1073/pnas.100127597.
25. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97:6640-6645. http://dx.doi.org/10.1073/pnas.120163297.
26. Grant AJ, Restif O, McKinley TJ, Sheppard M, Maskell DJ, Mastroeni P. 2008. Modelling within-host spatiotemporal dynamics of invasive bacterial disease. PLoS Biol 6:e74. http://dx.doi.org/10.1371/journal.pbio.0060074.
27. Hautefort I, Proença MJ, Hinton JCD. 2003. Single-copy green fluorescent protein gene fusions allow accurate measurement of Salmonella gene expression in vitro and during infection of mammalian cells. Appl Environ Microbiol 69:7480-7491. http://dx.doi.org/10.1128/AEM.69.12.7480-7491.2003.
28. Martin M. 2011. Cutadapt removes adapter sequences from highthroughput sequencing reads. EMBnet J 17:10.
29. Li H. 2013. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv:1303.3997. http://arxiv.org/abs/1303.3997.
30. Love MI, Huber W, Anders S. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550. http://dx.doi.org/10.1186/s13059-014-0550-8.
31. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57:289-300.
32. Chaudhuri RR, Morgan E, Peters SE, Pleasance SJ, Hudson DL, Davies HM, Wang J, van Diemen PM, Buckley AM, Bowen AJ, Pullinger GD, Turner DJ, Langridge GC, Turner AK, Parkhill J, Charles IG, Maskell DJ, Stevens MP. 2013. Comprehensive assignment of roles for Salmonella typhimurium genes in intestinal colonization of food-producing animals. PLoS Genet 9(4):e1003456. http://dx.doi.org/10.1371/journal.pgen.1003456.
33. Paterson GK, Northern H, Cone DB, Willers C, Peters SE, Maskell DJ. 2009. Deletion of tolA in Salmonella Typhimurium generates an attenuated strain with vaccine potential. Microbiology 155:220-228. http://dx.doi.org/10.1099/mic.0.021576-0.
34. Tacket CO, Sztein MB, Losonsky MB, Wasserman GA, Nataro SS, Edelman JP, Pickard R, Dougan D, Chatfield GSN, Levine MM. 1997. Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect Immun 65:452-456.
35. Dougan G, Chatfield CO, Pickard S, Bester D, O'Callaghan D, Maskell D. 1988. Construction and characterisation of vaccine strains of Salmonella harbouring mutations in two different aro genes. J Infect Dis 158: 1329-1335. http://dx.doi.org/10.1093/infdis/158.6.1329.
36. Hindle Z, Chatfield SN, Phillimore J, Bentley M, Johnson J, Cosgrove CA, Ghaem-Maghami M, Sexton A, Khan M, Brennan FR, Everest P, Wu T, Pickard D, Holden DW, Dougan G, Griffin GE, House D, Santangelo JD, Khan SA, Shea JE, Feldman RG, Lewis DJ. 2002. Characterization of Salmonella enterica derivatives harbouring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers. Infect Immun 70: 3457-3467. http://dx.doi.org/10.1128/IAI.70.7.3457-3467.2002.